BSECompany Update3d ago · 29 Oct 2026, 01:13 pm
We submit herewith Statement of Deviation or Variation in Utilization of Funds, for the half year ended on 30th September, 2026.
Cryogenic Ogs Ltd · 544440
✦ AI SummaryRegulatory
Cryogenic Ogs Ltd submitted a statement of deviation or variation in utilization of funds for the half year ended on 30th September, 2026, as per Regulation 32 of the SEBI LODR. The statement was reviewed by the audit committee and Board of the Company and is available on the company's website.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk6/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Cryogenic Ogs Ltd - 544440 - Statement Of Deviation Or Variation In Utilization Of Funds For The Half Year Ended On 30Th September, 2026.
Attachments (1)
📄pdf
Download →
42a007bc-7065-4c79-8eb6-6bb3b2907a36.pdf
View document text
Date: 29/10/2026
BSE Limited,
The Corporate Relationship Dept.,
Floor 25, P J Towers, Dalal Street, Mumbai 400 001.
Scrip Code: 544440
Sub: Statement of Deviation or Variation in Utilization of Funds, if any, under Regulation 32 of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) for the half
year ended on 30th September, 2026.
Sir,
In accordance with Regulation 32 of the SEBI LODR, we submit herewith the statement of deviation or
variation for the Half year ended 30th September 2026 as Annexure.
The statement of deviation/variation, pursuant to the above regulation, duly reviewed by the audit
committee and Board of the Company at its meeting held on 29th October, 2026, is enclosed herewith.
The above statement will also be available on the website of the Company at https://cryogenicogs.com
Kindly take the same into your records.
Thanking you,
Yours faithfully
For CRYOGENIC OGS LIMITED
RASHMI KAMLESH OTAVANI
Company Secretary & Compliance Officer